Navigation Links
7 out of 10 women too embarrassed to discuss vaginal dryness and pain with their physician
Date:5/18/2009

The majority of post-menopausal women are uncomfortable talking about vaginal dryness and pain and are reluctant to seek medical help, according to results from a new international survey presented today at the European Congress on Menopause in London. Results from the survey show that over a third (39 percent) of post-menopausal women experience these symptoms of vaginal atrophy and 40 percent of women who have recently experienced vaginal dryness and pain said it interferes with their sex life, yet seven out of ten would not discuss the problem with their physician (only 30 percent of women would consider talking to a gynaecologist, and only 29 percent would consider talking to a GP).

This reluctance to discuss the problem means a quarter would wait for over a year before finally contacting their physician. Additionally, more than a third of those surveyed did not know there are local treatments available.

"The results of this survey really highlight my experiences of treating menopausal women and in my practice in Italy it is even worse. I see many women who have vaginal dryness and pain post-menopause, and the most alarming aspect is that they wait for so long, with only 17 percent of surveyed women taking a treatment to counteract these symptoms." said Dr. Rossella Nappi, Director of the Gynecological Endocrinology & Menopause Unit at the Maugeri Foundation, University of Pavia, Italy. "In addition to the physical pain that affects the women, there is an emotional impact on them and their partner as well, and it is difficult for physicians to break the ice on such a sensitive issue. There is definitely a taboo factor involved as the survey shows that, of those who have experienced vaginal dryness and pain, 47 percent would rather speak to a female physician than a male physician about the problem."

Local symptoms such as painful intercourse, vaginal dryness, itching, burning, and soreness are caused, like other menopausal symptoms, by the gradual decline of oestrogen production in ovaries.

Despite the survey highlighting that so many women delay seeking treatment, it does show that 67 percent of those who have had or are currently taking treatment experience improvements, including an improved quality of life, a return to normal sexual activity, and an improvement in the relationship with their partner.

"The survey results highlight the need for doctors to be pro-active in addressing this taboo head-on by discussing vaginal health with their patients. In addition, I also strongly urge women experiencing vaginal dryness and pain to discuss the issue, as ignoring these symptoms may also lead to more serious long-term urogenital problems. Vaginal dryness and pain don't need to be considered as a natural part of growing older and effective treatment options, such as vaginal oestrogen tablets, pessaries, creams or rings are available and can easily be prescribed by their healthcare professional." said Professor Henry Burger, Consultant Endocrinologist, Jean Hailes Foundation for Women's Health, Melbourne, Australia.


'/>"/>

Contact: Polly Young
novonordisk@cohnwolfe.com
44-207-331-5365
Novo Nordisk Inc.
Source:Eurekalert

Related medicine news :

1. Program focused on body, mind and spirit helps women with breast cancer cope
2. Mayo Clinic researchers say agent provides treatment option for women with hot flashes
3. Menttium Offers Scholarship Award to Businesswomen Leaders
4. Womens Digital Imaging of Ridgewood First Private Medical Practice in New York Area to Screen With Breast Specific Gamma Imaging (BSGI)
5. CDC: Flu Drugs Should Be 1st Choice for Pregnant Women With Swine Flu
6. Siemens Hearing Celebrates 10th Annual National Womens Health Week
7. Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease
8. Southern AIDS Living Quilt Posts 100th Video Patch During National Womens Health Week
9. More Single Women Are Having Babies
10. Influenza pandemic planning needed to assure adequate care for pregnant women and newborns
11. New Study Shows Stresses of Economic Downturn on Womens Relationships
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... four time Emmy award winner and inspirational speaker Jan Fox will serve as ... by Speaking Boldly will provide participants with tools to more effectively communicate with ...
(Date:2/10/2016)... ... 10, 2016 , ... For additional information contact Phyllis Strupp 480-488-5858 , Brain ... Age: The Ultimate Guide to Brain Training" by award-winning author Phyllis Strupp ... date is March 16, 2016. A free review copy is available to the ...
(Date:2/10/2016)... West Palm Beach, Florida (PRWEB) , ... February ... ... Golf & Country Club) announced that it has been awarded the prestigious Distinguished ... of the World award program conducted by BoardRoom magazine, one of the most ...
(Date:2/10/2016)... Middleboro, MA (PRWEB) , ... February 10, 2016 ... ... of their revolutionary, biocompatible columns and accessories. These PEEK-lined stainless steel (PLS) columns ... to provide a solution that ensures the integrity of biological samples while operating ...
(Date:2/10/2016)... ... ... Workrite Ergonomics this week announced the launch of the Conform Monitor Arm Series, ... was to develop a product from the ground up that would provide the most ... Hulsey, Product Manager for Workrite Ergonomics. “The Conform series features a wide variety ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Feb. 10, 2016  CVS Health (NYSE: CVS ... in Santa Clara County, CA , ... the Santa Clara University campus. CVS Pharmacy stores and ... patients against the disease. Students at Santa Clara University ... vaccinated. In addition, anyone who has had close contact ...
(Date:2/10/2016)... Feb. 10, 2016 Immune Pharmaceuticals Inc. (NASDAQ: ... today that it has filed a patent application directed ... cancers. --> --> ... administration of Ceplene (histamine dihydrochloride) in combination with immune ... predicting the efficacy of Ceplene and IL-2 therapy in ...
(Date:2/10/2016)... TOKYO , Feb. 10, 2016  Astellas Pharma ... , "Astellas") announced today that it has successfully completed, ... a tender offer to purchase all issued and outstanding ... OCAT, President and CEO: Paul Wotton , "Ocata") ... the stockholder in cash ("Tender Offer"). Astellas commenced the ...
Breaking Medicine Technology: